Drug Database
Back to search

United States· US:70515-701_fa248cfa-08c9-43a3-8289-a28e5447cb1d

Omnaris

A ciclesonide product containing ciclesonide, registered in United States by Covis Pharma US, Inc. The same ATC class is registered in 2 of our 19 countries.

ATC R01AD13

Checked against FDA National Drug Code directory (United States) on

Informational only — not a medical device.

SOURCE REGISTER · USFDA National Drug Code directory (Unite…normalisedOmnarisATCR01AD13REGISTER NO.US:70515-701_fa248cfa…PACKS LISTED2CHECKEDSeptember 27, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about ciclesonideAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Ciclesonide is registered in 2 of 19 countries.

Countries holding a registration under ATC R01AD13 (ciclesonide), each read from that country’s own register.

  • This record: United States, from FDA National Drug Code directory (United States)
  • 1 of them publish a price we can compare per daily dose
Search ciclesonide products by name

Ciclesonide · ATC R01AD13

2 / 19 countries

  • Canada
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FDA National Drug Code directory (United States)
Active substance
CICLESONIDE
Manufacturer
Covis Pharma US, Inc
Country
United States (US)
ATC code
R01AD13
ATC class
Ciclesonide
Defined daily dose
0.2 mg, N
Reimbursed
Not published by this register
Source register
FDA National Drug Code directory (United States)
Last checked
September 27, 2026

Packs & prices · 2

  • ndc11
    7051570101
    1 POUCH in 1 CARTON (70515-701-01) / 1 BOTTLE, GLASS in 1 POUCH / 120 SPRAY in 1 BOTTLE, GLASS
  • ndc11
    70515-701-01

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

35 interactions on record for ciclesonide.

Graded by severity as the source publishes them — 35 moderate. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check ciclesonide against other medicinesHow interaction checks work

Ciclesonide · interactions on record

35 records

  • 35 moderate

Most severe, free to view

  • MiconazoleA07AC01moderate
  • LonafarnibA16AX20moderate
  • ConivaptanC03XA02moderate
  • KetoconazoleH02CA03moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Ciclesonide in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All ciclesonide products

Authorised across Europe · EMA

The same active substance is authorised in 23 EEA countries. Names it is sold under:

  • Austria · Alvesco, Ciclesonid Genetic
  • Bulgaria · Alvesco, Алвеско
  • Cyprus · Alvesco
  • Czechia · Alvesco, Ciclesonide Glenmark
  • Germany · Alvesco, Ciclesonid Glenmark
  • Denmark · Alvesco, Ciclasonide Glenmark
  • Spain · Alvesco
  • Finland · Alvesco, Ciclesonide Glenmark
  • France · Alvesco
  • United Kingdom (Northern Ireland) · Alvesco, Ciclesonide Advanz Pharma
  • Greece · Alvesco, Ciclair
  • Croatia · Airclesio, Alvesco
  • Hungary · Alvesco, Ciclesonid Sandoz
  • Ireland · Alvesco
  • Italy · Airven, Alvesco
  • Latvia · Alvesco
  • Netherlands · Alvesco Inhalator, Ciclesonide Ace
  • Norway · Alvesco, Ciclesonide Glenmark
  • Poland · Alvesco, Cyxezon
  • Romania · Alvesco Inhaler
  • Sweden · Alvesco, Ciclesonide Glenmark
  • Slovenia · Alvesco, Cmykle
  • Slovakia · Airclesio, Alvesco

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/26b07abf-7191-44ec-ba00-4c85035abacf
GET /v1/drugs/26b07abf-7191-44ec-ba00-4c85035abacf?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "route": "NASAL",
  "source": "ndc",
  "strength": "50",
  "substance": "CICLESONIDE",
  "productndc": "70515-701",
  "dosage_form": "SPRAY",
  "dea_schedule": null,
  "strength_unit": "ug/1",
  "application_number": "NDA022004",
  "marketing_category": "NDA"
}
API referenceMCP serverPlans

See everything about ciclesonide.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console